Atreca, Inc. Shareholders Equity (Total)

Shareholders Equity (Total) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Total) growth rates and interactive chart. Shareholder equity, also referred to as shareholders' equity and stockholders' equity, it a corporation's owners' residual claim after debts have been paid. Equity is equal to a firm's total assets minus its total liabilities. It is found on a company's balance sheet and it's the total equity available to common shareholders (after accounting for preferred equity). Also called book value or net book value.

Highlights and Quick Summary

  • Shareholders Equity (Total) for the quarter ending September 30, 2022 was $96.3 Million (a -16.45% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Total) decreased by -37.87%
  • Annual Shareholders Equity (Total) for 2021 was $155 Million (a -35.99% decrease from previous year)
  • Annual Shareholders Equity (Total) for 2020 was $242 Million (a 29.48% increase from previous year)
  • Annual Shareholders Equity (Total) for 2019 was $187 Million (a -300.95% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Total) of Atreca, Inc.

Most recent Shareholders Equity (Total)of BCEL including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Total) of Atreca, Inc.

Atreca, Inc. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $96.25 $115.2 $137.78
2021 $154.93 $175.43 $198.6 $221.4 $154.93
2020 $242.06 $261.28 $154.12 $170.14 $242.06
2019 $186.95 $205.0 $218.88 $0.0 $186.95
2018 $-93.03 $0.0 $0.0 $-93.03
2017 $-56.57

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology